Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
This is a randomized drug study that will examine if there is a difference between a daily oral LUM- 201 (study drug) and the standard of care drug, Norditropin, over ...
This is a randomized drug study that will examine if there is a difference between a daily oral LUM- 201 (study drug) and the standard of care drug, Norditropin, over ...
This is a randomized drug study that will examine if there is a difference between a daily oral LUM- 201 (study drug) and the standard of care drug, Norditropin, over ...
To evaluate the effect of tildacerfont in reducing A4 (androstenedione) in subjects with CAH (Congenital Adrenal Hyperplasia) over 12 weeks. ...
To evaluate the effect of tildacerfont in reducing A4 (androstenedione) in subjects with CAH (Congenital Adrenal Hyperplasia) over 12 weeks. ...
This study is being done to: • Compare the safety and effects of the study drugs, called empagliflozin and linagliptin with a placebo, in children and adolescents with type 2 ...
We will investigate the effects of the hormone angiotensin-(1-7) on energy expenditure in patients with obesity. ...
We will investigate the effects of the hormone angiotensin-(1-7) on energy expenditure in patients with obesity. ...
We will investigate the effects of the hormone angiotensin-(1-7) on energy expenditure in patients with obesity. ...
Hormones are molecules that deliver signals throughout the body. They influence behavior, sleep, hunger, stress, and virtually all other aspects of life. This study seeks to better understand several of ...
